Compounds > ibafloxacin
Page last updated: 2024-08-25

ibafloxacin and Benign Neoplasms

ibafloxacin has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV2

Other Studies

2 other study(ies) available for ibafloxacin and Benign Neoplasms

ArticleYear
Comparative in vitro activity of the two new 4-quinolones S-25930 and S-25932 against gram-positive bacteria isolated from cancer patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:5

    Topics: Anti-Bacterial Agents; Bacillus; Gram-Positive Bacteria; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Neoplasms; Quinolizines; Staphylococcus; Streptococcus

1988
In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Humans; Naphthyridines; Neoplasms; Quinolizines

1987